Ongoing lawsuits allege GLP-1s can cause serious harm. But we don’t know how often
Scant data about serious adverse effects makes it harder to answer scientific and legal questions about how often the drugs…
The U.S. has more thalidomide survivors than the government admits
In the 1950s and 1960s, doctors gave the drug thalidomide to pregnant patients without telling them — and without FDA…
Will FDA advisers recommend a multi-cancer blood test for approval? They’ll vote
The company Grail says its Galleri blood test can detect up to 50 forms of cancer. An independent panel of…
Record cyclosporiasis outbreak tests the response of a ‘weakened’ health system
From state and local food-safety response to the federal health agencies that fund that work, a record-breaking year for cyclosporiasis…
What to know about Dr. Heidi Overton, Trump’s pick to lead the FDA
Dr. Heidi Overton is currently working as a White House policy aide. If confirmed, she would lead an agency of…
Who really needs testosterone?
The military plans to start screening service members for low testosterone, and social media is overflowing with claims about testosterone…
What would it take to get peptides on the shelf?
An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for…
FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned
The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its…
FDA panel considers easing peptide restrictions
Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the…
Peptides get their regulatory closeup
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized…